Marking Myeloma Awareness Month, Medanta Hospital Noida, in association with Piku Sports, successfully organized the ‘Medanta Noida Awareness Run March for Myeloma’, bringing together the community to raise awareness about multiple myeloma and reinforce the message that the condition is treatable with timely intervention and advanced care.
The run witnessed enthusiastic participation from over 1500 individuals, including doctors, hospital staff, management, patients, cancer survivors, and local residents. The event featured multiple categories 10 km, 5 km, and 3 km runs, along with a special 1 km walk dedicated to cancer survivors, celebrating their resilience and inspiring others.
Flagged off at 6:00 AM from the hospital premises, the run was meticulously organized with a strong focus on participant comfort and safety. Runners were provided with high-quality T-shirts, hydration support along the route, energy drinks, finisher medals, certificates, and post-run refreshments. Dedicated medical teams were stationed throughout the route to ensure immediate assistance if required. The event also included engaging activities and interactive sessions, making it both informative and enjoyable.
Awards were presented to the top three male and female finishers in the overall category, along with age-wise winners across groups—under 18, 18 to 45, 45 to 60, and 60 years and above encouraging participation across all age segments.
Emphasizing the importance of awareness and advancements in treatment for Myeloma, Dr Esha Kaul, Director- Hemato-Oncology & Bone Marrow Transplant, Medanta Hospital Noida said, “Multiple myeloma is a type of blood cancer that affects plasma cells in the bone marrow. It often presents with symptoms such as persistent bone pain, fatigue, recurrent infections, unexplained weight loss, and kidney-related issues. Unfortunately, these symptoms are often overlooked or misattributed, leading to delayed diagnosis. However, with increasing awareness and timely screening, early detection is possible. Importantly, recent advancements in treatment, particularly in Bone Marrow Transplant (BMT), targeted therapies, and immunotherapy, have significantly improved patient outcomes. Today, myeloma is not only manageable but, in many cases, treatable, allowing patients to lead longer and better-quality lives.”
Dr Esha further added,
“The Myeloma Awareness Run reflects our commitment to spreading awareness about blood cancers and encouraging early diagnosis. Through such community-driven initiatives, we aim to educate people about symptoms, risk factors, and the importance of timely medical attention. The overwhelming participation we witnessed today is a testament to the growing awareness and collective responsibility towards health. It is heartening to see people from all walks of life come together for a meaningful cause and support patients battling myeloma.”
The ‘Medanta Noida Awareness Run’ stands as a powerful reminder that awareness, early detection, and access to advanced treatment can make a significant difference in the fight against myeloma.
